Henry Schein Debt to Equity Ratio 2012-2026 | HSIC
Current and historical debt to equity ratio values for Henry Schein (HSIC) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Henry Schein debt/equity for the three months ending June 30, 2026 was 0.60.
| Henry Schein Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2026-06-30 | $7.56B | $3.82B | 1.98 |
| 2026-03-31 | $7.39B | $3.92B | 1.88 |
| 2025-12-31 | $7.32B | $3.90B | 1.88 |
| 2025-09-30 | $7.07B | $4.02B | 1.76 |
| 2025-06-30 | $6.82B | $4.09B | 1.67 |
| 2025-03-31 | $6.53B | $3.95B | 1.65 |
| 2024-12-31 | $6.19B | $4.03B | 1.54 |
| 2024-09-30 | $6.47B | $4.14B | 1.56 |
| 2024-06-30 | $6.10B | $4.15B | 1.47 |
| 2024-03-31 | $5.91B | $4.24B | 1.39 |
| 2023-12-31 | $6.28B | $4.29B | 1.47 |
| 2023-09-30 | $5.53B | $4.28B | 1.29 |
| 2023-06-30 | $4.96B | $4.19B | 1.19 |
| 2023-03-31 | $4.45B | $4.13B | 1.08 |
| 2022-12-31 | $4.51B | $4.10B | 1.10 |
| 2022-09-30 | $4.29B | $4.25B | 1.01 |
| 2022-06-30 | $4.10B | $4.23B | 0.97 |
| 2022-03-31 | $4.22B | $4.22B | 1.00 |
| 2021-12-31 | $4.42B | $4.06B | 1.09 |
| 2021-09-30 | $4.32B | $4.11B | 1.05 |
| 2021-06-30 | $4.12B | $4.01B | 1.03 |
| 2021-03-31 | $3.78B | $4.00B | 0.95 |
| 2020-12-31 | $3.79B | $3.98B | 0.95 |
| 2020-09-30 | $4.02B | $3.79B | 1.06 |
| 2020-06-30 | $3.70B | $3.62B | 1.02 |
| 2020-03-31 | $3.91B | $3.61B | 1.09 |
| 2019-12-31 | $3.52B | $3.63B | 0.97 |
| 2019-09-30 | $3.64B | $3.46B | 1.05 |
| 2019-06-30 | $3.67B | $3.45B | 1.06 |
| 2019-03-31 | $3.73B | $3.42B | 1.09 |
| 2018-12-31 | $4.96B | $3.54B | 1.40 |
| 2018-09-30 | $4.97B | $3.42B | 1.46 |
| 2018-06-30 | $4.89B | $2.92B | 1.67 |
| 2018-03-31 | $5.00B | $2.91B | 1.72 |
| 2017-12-31 | $5.04B | $2.82B | 1.78 |
| 2017-09-30 | $4.47B | $3.02B | 1.48 |
| 2017-06-30 | $4.16B | $2.94B | 1.42 |
| 2017-03-31 | $4.05B | $2.80B | 1.45 |
| 2016-12-31 | $3.96B | $2.80B | 1.41 |
| 2016-09-30 | $3.73B | $2.90B | 1.29 |
| 2016-06-30 | $3.68B | $2.96B | 1.24 |
| 2016-03-31 | $3.68B | $2.92B | 1.26 |
| 2015-12-31 | $3.62B | $2.89B | 1.25 |
| 2015-09-30 | $3.43B | $2.94B | 1.17 |
| 2015-06-30 | $3.24B | $2.87B | 1.13 |
| 2015-03-31 | $3.20B | $2.74B | 1.17 |
| 2014-12-31 | $3.32B | $2.82B | 1.18 |
| 2014-09-30 | $3.31B | $2.82B | 1.17 |
| 2014-06-30 | $3.14B | $2.85B | 1.10 |
| 2014-03-31 | $3.06B | $2.82B | 1.09 |
| 2013-12-31 | $2.84B | $2.79B | 1.02 |
| 2013-09-30 | $2.57B | $2.71B | 0.95 |
| 2013-06-30 | $2.55B | $2.62B | 0.97 |
| 2013-03-31 | $2.63B | $2.58B | 1.02 |
| 2012-12-31 | $2.72B | $2.62B | 1.04 |
| 2012-09-30 | $2.54B | $2.57B | 0.99 |
| 2012-06-30 | $2.35B | $2.49B | 0.94 |
| 2012-03-31 | $2.23B | $2.53B | 0.88 |
| 2011-12-31 | $2.31B | $2.43B | 0.95 |
| 2011-09-30 | $2.26B | $2.54B | 0.89 |
| 2011-06-30 | $2.31B | $2.58B | 0.90 |
| 2011-03-31 | $2.35B | $2.45B | 0.96 |
| 2010-12-31 | $2.14B | $2.41B | 0.89 |
| 2010-09-30 | $2.24B | $2.37B | 0.94 |
| 2010-06-30 | $2.15B | $2.27B | 0.95 |
| 2010-03-31 | $2.07B | $2.19B | 0.95 |
| 2009-12-31 | $1.67B | $2.16B | 0.78 |
| 2009-09-30 | $1.63B | $2.07B | 0.79 |
| 2009-06-30 | $1.47B | $2.17B | 0.68 |
| 2009-03-31 | $1.41B | $2.02B | 0.70 |
| 2008-12-31 | $1.83B | $1.77B | 1.03 |
| 2008-09-30 | $1.56B | $1.95B | 0.80 |
| 2008-06-30 | $1.54B | $1.93B | 0.80 |
| 2008-03-31 | $1.50B | $1.89B | 0.80 |
| 2007-12-31 | $1.53B | $1.78B | 0.86 |
| 2007-09-30 | $1.61B | $1.67B | 0.96 |
| 2007-06-30 | $1.33B | $1.57B | 0.85 |
| 2007-03-31 | $1.31B | $1.51B | 0.87 |
| 2006-12-31 | $1.41B | $1.47B | 0.96 |
| 2006-09-30 | $1.31B | $1.41B | 0.93 |
| 2006-06-30 | $1.30B | $1.36B | 0.96 |
| 2006-03-31 | $1.27B | $1.30B | 0.98 |
| 2005-12-31 | $1.33B | $1.25B | 1.07 |
| 2005-09-30 | $1.28B | $1.20B | 1.07 |
| 2005-06-30 | $1.28B | $1.16B | 1.10 |
| 2005-03-31 | $1.21B | $1.13B | 1.07 |
| 2004-12-31 | $1.33B | $1.11B | 1.20 |
| 2004-09-30 | $1.15B | $1.06B | 1.09 |
| 2004-06-30 | $1.15B | $1.05B | 1.10 |
| 2004-03-31 | $0.80B | $1.03B | 0.78 |
| 2003-12-31 | $0.82B | $1.00B | 0.81 |
| 2003-09-30 | $0.75B | $0.95B | 0.78 |
| 2003-06-30 | $0.71B | $0.91B | 0.78 |
| 2003-03-31 | $0.66B | $0.89B | 0.74 |
| 2002-12-31 | $0.70B | $0.86B | 0.81 |
| 2002-09-30 | $0.70B | $0.82B | 0.85 |
| 2002-06-30 | $0.63B | $0.78B | 0.82 |
| 2002-03-31 | $0.60B | $0.71B | 0.85 |
| 2001-12-31 | $0.71B | $0.68B | 1.04 |
| 2001-09-30 | $0.63B | $0.65B | 0.96 |
| 2001-06-30 | $0.58B | $0.62B | 0.94 |
| 2001-03-31 | $0.58B | $0.60B | 0.98 |
| 2000-12-31 | $0.65B | $0.58B | 1.13 |
| 2000-09-30 | $0.63B | $0.55B | 1.15 |
| 2000-06-30 | $0.63B | $0.54B | 1.17 |
| 2000-03-31 | $0.65B | $0.53B | 1.23 |
| 1999-12-31 | $0.69B | $0.52B | 1.33 |
| 1999-09-30 | $0.67B | $0.50B | 1.34 |
| 1999-06-30 | $0.66B | $0.49B | 1.36 |
| 1999-03-31 | $0.67B | $0.47B | 1.41 |
| 1998-12-31 | $0.50B | $0.46B | 1.08 |
| 1998-09-30 | $0.49B | $0.46B | 1.08 |
| 1998-06-30 | $0.40B | $0.44B | 0.91 |
| 1998-03-31 | $0.34B | $0.42B | 0.80 |
| 1997-12-31 | $0.33B | $0.41B | 0.80 |
| 1997-09-30 | $0.28B | $0.32B | 0.87 |
| 1997-06-30 | $0.18B | $0.31B | 0.59 |
| 1997-03-31 | $0.15B | $0.29B | 0.49 |
| 1996-12-31 | $0.17B | $0.29B | 0.59 |
| 1996-09-30 | $0.15B | $0.28B | 0.55 |
| 1996-06-30 | $0.14B | $0.27B | 0.52 |
| 1996-03-31 | $0.16B | $0.15B | 1.08 |
| 1995-12-31 | $0.15B | $0.14B | 1.08 |
| 1995-09-30 | $0.00B | 0.00 | |
| 1995-06-30 | $0.00B | 0.00 | |
| 1995-03-31 | $0.00B | 0.00 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $9.754B | $13.184B |
| Henry Schein Inc. is a leading distributor of health care products and services across the globe. The company serves office-based dental, medical and animal health practitioners, dental laboratories, government as well as institutional health care clinics and other alternate-care sites. Henry Schein's 3 businesses - Dental, Medical and Technology and Value-Added Services serve millions of customers worldwide. Henry Schein has completed the spinoff of its global Animal Health business. The global dental group serves office-based dental practitioners, dental laboratories, schools and other institutions. The global medical group serves office-based medical practitioners, ambulatory surgery centers, other alternate-care settings and other institutions. The global technology and value-added services group provides software, technology and other value-added services to health care practitioners. The technology group offerings include practice management software systems for dental and medical practitioners. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| CONMED (CNMD) | United States | $1.406B | 9.82 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |